Vera Therapeutics to Host In-Person R&D Day in New York to P

BRISBANE, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company developing and commercializing transformative treatments for patients with serious immunologic diseases, today

Related Keywords

Leicester , United Kingdom , Stanford , Leicestershire , Long Island Jewish Medical Center , New York , United States , Brisbane , Queensland , Australia , American , America , Jonathan Barratt , Joyce Allaire , Richard Lafayette , Mari Purpura , Stanford University Department Of Medicine , Nephrology At Stanford University , Communications Committee , Stanford Glomerular Disease Center , Renal Research Group , Glomerular Disease Advisory Committee , American Society Of Nephrology , Lotte New York Palace Hotel , Stanford University School Of Medicine , American Society Of Nephrology Kidney Health Initiative , Exchange Commission , University Of Leicester , Vera Therapeutics Inc , College Of Life Sciences , Stanford University Medical Center , York Medical College , Igan Rare Disease Group , Nasdaq , Drug Administration , Castle Connolly Medical Ltd , International Igan Network , New York Palace Hotel , Stanford University Medical , New York Medical College , Stanford University School , Internal Medicine , Associate Chair , Stanford University Department , Clinical Chief , Stanford University , Top Doctors , Best Doctors , Top Doctors Award , Castle Connolly Medical , Editorial Board , Kidney News , American Society , Life Sciences , Disease Group , United Kingdom National Registry , Rare Kidney Diseases , Chief Investigator , Nephrology Kidney Health Initiative , Identifying Surrogate Endpoints , Clinical Trials , Private Securities Litigation Reform Act , Region ,